The creation of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Early routes focused on amino acid chain fragment coupling, utilizing https://mathefzoz696947.dm-blog.com/40987087/creation-and-investigation-implementations-of-retatrutide